Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar;12(1):44-50.
doi: 10.1208/s12248-009-9154-8. Epub 2009 Nov 20.

A history of biopharmaceutics in the Food and Drug Administration 1968-1993

Jerome Philip Skelly  1
Affiliations

A history of biopharmaceutics in the Food and Drug Administration 1968-1993

Jerome Philip Skelly. AAPS J. 2010 Mar.

Abstract

The history of biopharmaceutics is reviewed, beginning with its origin out of the Division of Clinical Research in The Bureau of Medicine. The reason for the creation of the Division of Biopharmaceutics, the certification of Food and Drug Administration authority over the functions it was to have, and the implementation of that authority are described. The determination of bioequivalence, the bioavailability decision rules, pharmacokinetics, and drug metabolism are explained. The reason for the development of the Scale-Up and Post Approval Regulations and how they were developed are also explained.

PubMed Disclaimer

References

    1. Seife, M. Evolution of the principal US food & drug laws. In: Sharma KN, Sharma KK, Sen P, editors. Generic drugs, bioequivalence and pharmacokinetics: Proceedings of the Indo-US Symposium, New Delhi, University College of Medical Sciences, 1990. Ring Road, New Delhi 110-029: University College of Medical Sciences; 1990. p. 7–14.
    1. U.S. Department of Health and Human Services. A brief history of the center for drug evaluation and research. 2009. http://www.fda.gov/cder/about/history/Histext.htm. Accessed March 2009.
    1. U.S. Department of Health and Human Services. A brief history of the center for drug evaluation and research. 2009. http://www.fda.gov/aboutFDA/whatwedo/history/thisweek/ucm117833.htm.
    1. Skelly JP. Bioavailability policies and guidelines; in industrial bioavailability and pharmacokinetics—guidelines and controls. In: Martin A, Doluisio JT, editors. College of pharmacy, drug dynamics institute. Austin: University of Texas; 1977. pp. 2–41.
    1. United States of America versus Pharmadyne Laboratories and Bernard Bedrick; United States District Court, District of New Jersey. 1980.

Publication types

MeSH terms

Substances

LinkOut - more resources